-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
![Immunoprecipitation of tumor associated ctDNA fragments for novel lung cancer liquid biopsy thumbnail](https://volition.com/wp-content/uploads/2024/03/Immunoprecipitation-of-tumor-associated-ctDNA-fragments-for-novel-lung-cancer-liquid-biopsy-thumbnail.png)
Immunoprecipitation of tumor associated ctDNA fragments for novel lung cancer liquid biopsy
- Share
- Tweet
- Share on Facebook
- Share
![Screenshot 2024-06-04 163643](https://volition.com/wp-content/uploads/2024/03/Screenshot-2024-06-04-163643.png)
![Screenshot 2024-06-04 163643](https://volition.com/wp-content/uploads/2024/03/Screenshot-2024-06-04-163643.png)
Poster titled: Immunoprecipitation of tumor associated ctDNA fragments for novel lung cancer liquid biopsy
Presented at: ELCC 2024
Pamart et al
Subscribe for Volition product updates.
Or, click here for Investor Updates and press releases.
"*" indicates required fields